TY - JOUR
T1 - Clinical impact of non-lying time on hospital-associated functional decline in older patients undergoing transcatheter aortic valve implantation
AU - Kono, Yuji
AU - Mukaino, Masahiko
AU - Ozawa, Yushi
AU - Mizutani, Koji
AU - Senju, Yuki
AU - Ogasawara, Takayuki
AU - Yamaguchi, Masumi
AU - Muramatsu, Takashi
AU - Izawa, Hideo
AU - Otaka, Yohei
N1 - Publisher Copyright:
© The Author(s) 2023.
PY - 2024/3
Y1 - 2024/3
N2 - The purposes of the present study were: (1) to investigate the relationship between hospital-associated functional decline (HAFD) and non-lying time and (2) to clarify the optimal cut-off value for non-lying time associated with HAFD in older patients undergoing transcatheter aortic valve implantation (TAVI). From January 2021 to December 2022, patients admitted to a university hospital who underwent trans-femoral TAVI were consecutively recruited. We measured short physical performance battery (SPPB) pre and post-TAVI, and non-lying time from post-operative days 3–5. HAFD was defined as at least 1 point decrease in SPPB during pre and post-TAVI. Among 75 patients (47 female, mean age of 84.5 years) enrolled, 14 patients were classified as having HAFD. Non-lying time was significantly shorter in the HAFD group than in the non-HAFD group (371 min vs. 539 min, P < 0.001). Receiver-operating characteristic analysis determined an optimal cut-off value of 477 min for differentiating the patients more likely to experience HAFD (sensitivity, 75%; specificity, 92%; area under the curve, 0.798). The non-lying time could be one of the associated factors of HAFD in older patients with TAVI. Non-lying time of about 480 min (8 h) during hospitalization may be an initial target for preventing HAFD.
AB - The purposes of the present study were: (1) to investigate the relationship between hospital-associated functional decline (HAFD) and non-lying time and (2) to clarify the optimal cut-off value for non-lying time associated with HAFD in older patients undergoing transcatheter aortic valve implantation (TAVI). From January 2021 to December 2022, patients admitted to a university hospital who underwent trans-femoral TAVI were consecutively recruited. We measured short physical performance battery (SPPB) pre and post-TAVI, and non-lying time from post-operative days 3–5. HAFD was defined as at least 1 point decrease in SPPB during pre and post-TAVI. Among 75 patients (47 female, mean age of 84.5 years) enrolled, 14 patients were classified as having HAFD. Non-lying time was significantly shorter in the HAFD group than in the non-HAFD group (371 min vs. 539 min, P < 0.001). Receiver-operating characteristic analysis determined an optimal cut-off value of 477 min for differentiating the patients more likely to experience HAFD (sensitivity, 75%; specificity, 92%; area under the curve, 0.798). The non-lying time could be one of the associated factors of HAFD in older patients with TAVI. Non-lying time of about 480 min (8 h) during hospitalization may be an initial target for preventing HAFD.
KW - Hospital-associated functional decline
KW - Non-lying time
KW - Older patients
KW - Transcatheter aortic valve implantation
UR - http://www.scopus.com/inward/record.url?scp=85174225154&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85174225154&partnerID=8YFLogxK
U2 - 10.1007/s00380-023-02326-w
DO - 10.1007/s00380-023-02326-w
M3 - Article
C2 - 37843551
AN - SCOPUS:85174225154
SN - 0910-8327
VL - 39
SP - 266
EP - 272
JO - Heart and Vessels
JF - Heart and Vessels
IS - 3
ER -